FORM 8-A
Securities and Exchange Commission
Washington, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ADVANCED MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State of incorporation or organization)
13-3492624
(I.R.S. Employer Identification Number)
9775 Businesspark Avenue
San Diego, California 92131
(Address of principal executive offices)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be so registered:
15% Subordinated Debentures Due July 15, 1999
Name of each exchange on which each class is to be registered:
American Stock Exchange
If this Form relates to the registration of a class of debt
securities and is effective upon filing pursuant to General
Instruction A.(c)(1), please check the following box. /x/
If this Form relates to the registration of a class of debt
securities and is to become effective simultaneously with the
effectiveness of a concurrent registration statement under the
Securities Act of 1933 pursuant to General Instruction A.(c)(2),
please check the following box. / /
Securities to be registered pursuant to Section 12(g) of the
Act:
__________________________________
(Title of class)
_________________________________
(Title of class)
<PAGE>
ITEM 1. Description of Registrant's Securities to be Registered
For a description of the 15% Subordinated Debentures Due
July 15, 1999 of the Registrant, see Schedule 13E-4 Issuer Tender
Offer Statement of Advanced Medical, Inc. dated April 21, 1995,
which is hereby incorporated by reference.
ITEM 2. Exhibits
1. Form of the 15% Subordinated Debentures due July
15, 1999 of the Registrant (Included within the
Indenture filed as Exhibit 2(a)).
2(a). Indenture for the 15% Subordinated Debentures due
July 15, 1999 of the Registrant between the
Registrant and the United States Trust Company of
New York (the "Indenture"). (Incorporated by
reference to Exhibit (c)(4) to the Schedule 13E-4
Issuer Tender Offer Statement of Advanced Medical,
Inc. dated April 21, 1995). (Incorporated by
reference to Exhibit (c)(4) to the Schedule 13E-4
Issuer Tender Offer Statement of Advanced Medical,
Inc. dated April 21, 1995)
2(b). Certificate of Incorporation of the Applicant and
form of Certificate of Incorporation of the
Applicant, as amended. (Incorporated by reference
to Exhibit 3.1(a) to the Prospectus/Joint Proxy
Statement dated March 3, 1989 of Fidata
Corporation, Advanced Medical, Inc. and Controlled
Therapeutics Corporation included and forming part
of the Registration Statement on Form S-4 of
Advanced Medical, Inc. (the "Prospectus/Joint
Proxy Statement").)
2(c). Amendments to Articles First and Fourth of the
Restated Certificate of Incorporation of the
Applicant. (Incorporated by reference to Exhibits
A and B to Advanced Medical, Inc.'s Proxy
Statement dated August 15, 1990 for its Special
Meeting of Stockholders held on September 7,
1990.)
2(d). Form of Certificate of Voting Powers, Designation,
Rights, Preferences and Restrictions of 10%
Cumulative Preferred Stock. (Incorporated by
reference to Appendix A to Prospectus/Joint Proxy
Statement.)
2(e). Form of Certificate of Voting Powers, Designation,
Rights, Preferences and Restrictions of
Convertible Preferred Stock. (Incorporated by
reference to Advanced Medical, Inc.'s annual
report on Form 10-K for the year ended December
31, 1990.)
2(f). Certificate of Amendment of Restated Certificate
of Incorporation of the Applicant dated August 11,
1994. (Incorporated by reference to Advanced
Medical, Inc.'s Form T-3 dated February 8, 1995.)
SIGNATURE
Pursuant to the requirements of Section 12 of the
Securities Exchange Act of 1934, the registrant has duly caused
this registration statement to be signed on its behalf by the
undersigned, thereto duly authorized.
(Registrant): Advanced Medical, Inc.
Date: 6/9/95
By: /s/ Joseph W. Kuhn
Name: Joseph W. Kuhn
Title: President
